Medirom Healthcare Technologies (NASDAQ:MRM) Stock Price Up 4.5% – Still a Buy?

Medirom Healthcare Technologies Inc. (NASDAQ:MRM) shares were up 4.5% during mid-day trading on Wednesday . The company traded as high as $1.39 and last traded at $1.39. Approximately 15,554 shares changed hands during trading, a decline of 58% from the average daily volume of 36,626 shares. The stock had previously closed at $1.33.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Medirom Healthcare Technologies in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Medirom Healthcare Technologies currently has a consensus rating of “Sell”.

Medirom Healthcare Technologies Price Performance

The stock has a 50-day moving average of $1.69. The company has a quick ratio of 0.21, a current ratio of 0.24 and a debt-to-equity ratio of 2.42.

Medirom Healthcare Technologies (NASDAQ:MRM) last posted its earnings results on Tuesday, October 21st. The company reported ($0.30) earnings per share for the quarter. The firm had revenue of $11.28 million for the quarter.

Medirom Healthcare Technologies Company Profile

MEDIROM Healthcare Technologies Inc provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.